Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,360.2
12.3 (0.37%)

 

  • STI Straits Times Index
    3,360.2
    12.3 (0.37%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,669.4
    -3.0 (-0.18%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,538.3
    -16.6 (-0.06%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,936.0
    -6.1 (-0.21%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,526.2
    -159.7 (-0.74%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,402.2
    -16.0 (-0.25%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,083.6
    1.2 (0.06%)
    Index delayed 20 minutes
  • XAO XAO
    6,752.7
    6.5 (0.10%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 245.3M
  • Value: 251.7M
  • Rise: 150
  • Fall: 79
  • Unch: 608

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Asian Pay Tv Tr0.191+0.005
Sino Grandness0.048+0.003
Koh Eco0.053+0.006
SunMoonFood^0.053+0.001
Anchor Resources0.015+0.001
IEV0.040+0.003
ThaiBev0.845-
Spackman0.017-
SPH2.270-0.050
FJ Benjamin^0.038+0.003

World Indices

World Indices
Name Last Change
Nasdaq 8,258.2 +14.1
HSI 28,540.4 -14.5
HSCEI 10,814.0 -25.0
Jakarta 6,402.4 -15.8
Nikkei 225 21,526.2 -159.7
SSE Comp 2,936.0 -6.1
Shanghai A 3,075.2 -6.4
Shanghai B 290.8 -0.9
ShenZhen A 1,642.9 -1.4
ShenZhen B 976.4 -3.3
Taiwan W 10,881.6 +5.2
PSE Comp 0.0
KOSPI 2,083.8 +1.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AGILENT TECHNOLOGIES INC AGILENT TECHNOLOGIES INC
Updated on 15 Jul 2019 (End of trading day)
Last (USD): 70.550 Change: -1.100 High: 71.020 Remarks: -
Change (%): -1.54 Low: 69.485
Open 71.020 Yesterday's Close 71.64999999999999
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 3,955,265 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 1.00002 Trailing EPS (USD) e 3.53489 NAV (USD) b 16.2187
PE a 70.549 Trailing PE f 19.958 Price / NAV b 4.3499
Dividend (USD) d 0.599785 Cash In Hand (USD) g 6.8198 Issued & Paid-up Shares c 315,993,000
Dividend Yield (%) d 0.850 Price / Cash In Hand g 10.345 Treasury Shares h 9,000
Beta - 75 Daysi 0.212 R-Squared - 75 Days(%)i 2.89 Market Cap (M) 22,293.306
Beta - 500 Daysi 0.141 R-Squared - 500 Days (%)i 0.77 Enterprise Value (M) 21,936.306
Piotroski F Score 7 Exchange Code A Par Value ( $ ) n.a.
52 Weeks Volatility (%) 26.45 Free Float (%) 99.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 03 Jun 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 15 May 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AGILENT TECHNOLOGIES INC NYSE 22,293.306 70.549 19.958 4.3499 0.850
Industry Biotechnology NYSE 4,416.229 678.548 33.093 4.0703 0.715
Local Peer EMERGENT BIOSOLUTIONS INC NYSE 2,237.956 35.693 53.682 2.2663 -
Local Peer MYOVANT SCIENCES LTD NYSE 790.475 - - 182.2314 -
Local Peer ARCUS BIOSCIENCES INC NYSE 370.977 - - 1.4547 -
Local Peer KADMON HLDGS INC NYSE 321.110 - - 3.9910 -
Local Peer ENZO BIOCHEM INC NYSE 185.472 - 87.818 2.0381 -
Global Peer AMGEN INC NASDAQ 107,421.928 12.797 13.303 9.9171 3.095
Global Peer GILEAD SCIENCES INC NASDAQ 86,555.089 15.867 14.690 3.9431 3.377
Global Peer AMGEN-T HKEx 609,936.000 9.271 9.631 7.1731 4.272
Global Peer CSL ASX 100,306.849 44.954 41.174 14.5537 1.030
Global Peer CELGENE CORP NASDAQ 64,714.658 15.995 13.638 7.9259 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 45,172.061 21.548 20.963 9.5637 -
Global Peer BIOGEN INC NASDAQ 45,297.283 10.224 9.707 3.2753 -
Global Peer ILLUMINA INC NASDAQ 44,436.630 53.797 52.217 11.1510 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,694.156 13.375 13.468 3.4616 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 27,590.120 355.545 66.259 2.8424 -
Other Global Peers INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SINO BIOPHARM (HKEx), SAREPTA THERAPEUTICS INC (NASDAQ), WUXI BIO (HKEx), ARRAY BIOPHARMA INC (NASDAQ), SEATTLE GENETICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BEIGENE (HKEx), EXELIXIS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), 3SBIO (HKEx), GENSCRIPT BIO (HKEx), TILRAY INC (NASDAQ), REPLIGEN CORP (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ALKERMES PLC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ACCELERON PHARMA (NASDAQ), GENOMIC HEALTH INC (NASDAQ), INSMED INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), NATERA INC (NASDAQ), REGENXBIO INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), VERACYTE INC (NASDAQ), ALECTOR INC (NASDAQ), EPIZYME INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), HAOHAI BIOTEC (HKEx), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), RETROPHIN INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), FRONTAGE (HKEx), HOMOLOGY MEDICINES INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VIVA BIOTECH (HKEx), ASCLETIS-B (HKEx), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), POLYNOVO LIMITED (ASX), PERSONALIS INC (NASDAQ), MACROGENICS INC (NASDAQ), OMEROS CORP (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), VANDA PHARMACE INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD (ASX), GLYCOMIMETICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CKLIFE SCIENCES (HKEx), MESOBLAST LTD (ASX), KODIAK SCIENCES INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), NEXT SCIENCE LTD (ASX), MAGENTA THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ESSEX BIO-TECH (HKEx), MERIDIAN BIOSCIENCE INC COM (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), DERMIRA INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), MEDICINOVA INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), LEE'S PHARM (HKEx), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), PROTHENA CORP PLC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NEXTCURE INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), IMMUNOGEN INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AGENUS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), RESTORBIO INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), ACHILLION PHARMACEUTICALS INC (NASDAQ), AVROBIO INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SYNLOGIC INC (NASDAQ), TELIX PHARMACEUTIC (ASX), GERON CORP (NASDAQ), ATHERSYS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), KAMADA (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), DPHARMA (Bursa), CALITHERA BIOSCIENCES INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), MANNKIND CORPORATION (NASDAQ), CHIASMA INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), SERES THERAPEUTICS (NASDAQ), AFFIMED N V (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), STANDARD DIVERSIFIED INC (NYSE American), X4 PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), IMV INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ARDELYX INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), PFENEX INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), TOCAGEN INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), BBI LIFE SCI (HKEx), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), BIOTIME INC (NYSE American), PARATEK PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), HEMISPHERX BIOPHARMA INC (NYSE American), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ADURO BIOTECH INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), AVEO PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), NANTKWEST INC (NASDAQ), INMUNE BIO INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), FORTRESS BIOTECH INC (NASDAQ), TREVENA INC (NASDAQ), EQUILLIUM INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), UNI-BIO GROUP (HKEx), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), PORT (SET), SAVARA INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), VERMILLION INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), EDAP TMS S.A. SPON ADS EACH REPR 1 ORD SHARE (NASDAQ), RESAPP HEALTH LIMITED (ASX), ALPINE IMMUNE SCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), CURIS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), IDERA PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), COHBAR INC (NASDAQ), ORGENESIS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ARAVIVE INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), IBIO INC (NYSE American), CORREVIO PHARMA CORP (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD (ASX), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), REGENT PACIFIC (HKEx), CT ENTERPRISE (HKEx), AQUINOX PHARMACEUTICALS INC (NASDAQ), CEL-SCI CORP (NYSE American), OUTLOOK THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ORTHOCELL LIMITED (ASX), VASCULAR BIOGENICS LTD (NASDAQ), IVERIC BIO INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), VACCINEX INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), PHYLOGICA LIMITED (ASX), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), ZAFGEN INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMUGENE LIMITED (ASX), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), ZELDA THERAPEUTICS LTD (ASX), APTEVO THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), CONTRAFECT CORP (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIOTRON (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), SENESTECH INC (NASDAQ), EXTRAWELL PHAR (HKEx), SOPHIRIS BIO INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), BIONANO GENOMICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), BIOSINO BIO-TEC (HKEx), RHINOMED LIMITED (ASX), ONCOLYTICS BIOTECH INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ORAGENICS INC (NYSE American), HEAT BIOLOGICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), ISORAY INC (NYSE American), REXAHN PHARMACEUTICALS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), CELLECTAR BIOSCIENCES INC (NASDAQ), ADALTA LTD (ASX), BIOCEPT INC (NASDAQ), PRECIPIO INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), HISTOGENICS CORP (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), SOLIGENIX INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), VICAL INC (NASDAQ), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ATYR PHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BIONOMICS LTD (ASX), PULMATRIX INCORPORATED (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ANTEO DIAGNOSTICS LIMITED (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), OHR PHARMACEUTICAL INC (NASDAQ), NANOVIRICIDES INC (NYSE American), MEMPHASYS LTD (ASX), NOVELION THERAPEUTICS INC (NASDAQ), CELLMID LIMITED (ASX), DARE BIOSCIENCE INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), IMMURON LIMITED (ASX), ADVAXIS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TROVAGENE INC (NASDAQ), VAXART INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), BIOXYNE LIMITED (ASX), CAPRICOR THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADR EA REPR 150 ORD(POST SPLIT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), Suntar Eco-City^ (SGX), HOLISTA COLLTECH LIMITED (ASX), CYCLACEL PHARMA IN (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADR EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), BENITEC BIOPHARMA LTD (ASX), ARCA BIOPHARMA INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), HAO WEN HLDGS (HKEx), MEGASUN (Bursa), QT Vascular (SGX), MGRC (Bursa), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), NEURALSTEM INC (NASDAQ), OPGEN INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), CCP TECHNOLOGIES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), CYTORI THERAPEUTICS INC (NASDAQ), NOVITA HEALTHCARE LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), TRILLIUM THERAPEUTICS INC (NASDAQ), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), MEDIBIO LIMITED (ASX), BPH ENERGY LIMITED (ASX), GENERA BIOSYSTEMS LIMITED (ASX), ALCHEMIA LIMITED (ASX), SINOVAC BIOTECH (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --2.900
-3.95 %
10 Days 0.164-5.060
-6.48 %
20 Days 0.164-1.360
-1.66 %
Medium Term Return 3 Months 0.164-7.000
-8.81 %
6 Months 0.328-0.050
+0.39 %
1 Year 0.641+7.510
+12.93 %
Long Term Return 2 Years 1.220+9.340
+17.25 %
3 Years 1.731+23.570
+53.85 %
5 Years 2.608+29.479
+78.13 %
Annualised Return Annualised --
+12.24 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 61.010 - 82.270 Change From 1 Year Low +9.540 % Change From 1 Year Low (%) +15.64
Change From 1 Year High -11.720 % Change From 1 Year High (%) -14.25
2 Years Range 58.220 - 82.270 Change From 2 Years Low +12.330 % Change From 2 Years Low (%) +21.18
Change From 2 Years High -11.720 % Change From 2 Years High (%) -14.25
5 Years Range 33.115 - 82.270 Change From 5 Years Low +37.435 % Change From 5 Years Low (%) +113.05
Change From 5 Years High -11.720 % Change From 5 Years High (%) -14.25
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment comprises activity providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Jul 2019 71.020 71.020 69.485 70.550 3,955,265 -
12 Jul 2019 71.280 72.270 70.830 71.650 2,542,351 -
11 Jul 2019 73.770 73.780 71.480 71.740 6,562,206 -
10 Jul 2019 73.580 73.940 73.130 73.370 1,773,943 -
09 Jul 2019 73.490 74.081 73.105 73.450 2,090,423 -
08 Jul 2019 75.530 75.985 73.500 73.840 2,190,383 -
05 Jul 2019 76.340 76.470 75.300 75.750 1,493,127 -
03 Jul 2019 75.860 76.930 75.700 76.800 1,153,149 -
02 Jul 2019 75.850 76.180 75.250 75.610 1,876,980 -
01 Jul 2019 75.600 75.890 74.920 75.780 2,752,790 -
28 Jun 2019 73.260 74.700 73.100 74.670 3,159,736 -
27 Jun 2019 72.550 73.280 72.200 73.190 1,480,248 -
26 Jun 2019 72.640 73.180 72.040 72.140 1,523,890 -
25 Jun 2019 73.190 73.630 72.410 72.510 1,340,355 -
24 Jun 2019 73.330 73.680 72.260 73.140 1,251,576 -
21 Jun 2019 73.140 73.540 72.550 73.340 3,096,151 -
20 Jun 2019 73.220 73.420 72.365 73.320 2,075,520 -
19 Jun 2019 71.890 72.730 71.890 72.650 1,906,358 -
18 Jun 2019 70.800 72.220 70.570 71.910 2,350,378 -
17 Jun 2019 70.250 70.600 69.890 70.290 1,149,172 -
14 Jun 2019 70.310 70.450 69.740 69.970 1,602,711 -
13 Jun 2019 70.560 70.710 69.890 70.300 1,886,929 -
Summary
Current 2 Weeks
(01 Jul 2019 to 15 Jul 2019)
75.600 76.930 69.485 70.550 26,390,617 -
Previous 2 Weeks
(17 Jun 2019 to 28 Jun 2019)
70.250 76.930 69.485 74.670 19,333,384 -
4 Weeks from
(17 May 2019 to 14 Jun 2019)
68.440 76.930 68.190 69.970 60,064,498 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.